Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.

导出 OA

翻译打印收藏纠错

作者： Laura W,Dillon ^[1] ; Jake,Higgins ^[2] ; Hassan,Nasif ^[3] ; Megan,Othus ^[3] ; Lan,Beppu ^[4] ; Thomas H,Smith ^[2] ; Elizabeth,Schmidt ^[2] ; Charles C,Valentine Iii ^[2] ; Jesse J,Salk ^[2] ; Brent L,Wood ^[5] ; Harry P,Erba ^[6] ; Jerald P,Radich ^[7] ; Christopher S,Hourigan ^[8]

作者单位： Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. ^[1] TwinStrand Biosciences, Seattle, WA. ^[2] Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA. ^[3] Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA. ^[4] Dept. of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA. ^[5] Duke University School of Medicine, Durham, NC. ^[6] Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA. ^[7] Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD. hourigan@nih.gov. ^[8]